Aprea Therapeutics's total assets for Q1 2025 were $20.22M, a decrease of -15.67% from the previous quarter. APRE total liabilities were $4.67M for the fiscal quarter, a <0.01% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.